Clinical Trial: Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07039669) titled 'Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease' on June 05.

Brief Summary: The objective of the study was to evaluate the efficacy and safety of 611 in Chinese adults with moderate to severe COPD.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Pulmonary Disease, Chronic Obstructive (COPD)

Intervention: DRUG: 611

611 subcutaneous (SC) injection

DRUG: Placebo

placebo Q2W, subcutaneous (SC) injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Disclaimer: Curated by HT Syndication....